2022

Perdiguero-Gil, Enrique and Bueno Vergara, Eduardo. «The role as –signed to health education in Spain during the transition to Democracy». Historia y Memoria de la Educación 15 (2022): 171-202. Abrir

 

2021
2020

 Mário C Scheffer, Maria Pastor-Valero, Giuliano Russo, Ildefonso Hernández-Aguado  «Revolving doors and conflicts of interest in health regulatory agencies in Brazil.» BMJ Global Health 5.4 (2020): e002325. Abrir

Scheffer MC, Pastor-Valero M, Cassenote AJF, Compañ Rosique AF.. «How many and which physicians? A comparative study of the evolution of the supply of physicians and specialist training in Brazil and Spain.» Human resources for health 18 (2020): 1-9. Abrir

Carolina La Maison, Jessica M Maruyama, Tiago N Munhoz, Iná S Santos, Mariana R do Amaral, Luciana Anselmi, Fernando C Barros, Maria Pastor-Valero, Alicia Matijasevich «Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort» . Abrir

2019

Turner S, Mayumi Maruyama J, Matijasevich A, Pastor-Valero M. Breastfeeding and the Development of Socio-Emotional Competencies: A Systematic Review. Abrir.

Maruyama JM, Pastor-Valero M, Santos IS, Munhoz TN, Barros FC, Matijasevich A.J. Impact of maternal depression trajectories on offspring socioemotional competences at age 11: 2004 Pelotas Birth Cohort. Abrir. 

Bueno Vergara E, Perdiguero Gil E. Enfermedad y muerte en la España moderna: el valor de los archivos locales. Revista do Arquivo (São Paulo), 2019; IV(8): 18-3. . ISSN 2447-908X. Abrir.

Perdiguero Gil, E. Health reforms in Greece, Italy and Spain: studies on the Mediterranean paradigm. Dynamis, 2019; 39(1): 13-20. ISSN: 0211-9536. Abrir.

Perdiguero-Gil E, Comelles, JM. (2019). The defence of health. The debates on health reform in 1970s Spain. Dynamis, 2019; 39(1): 45-72. ISSN: 0211-9536. Abrir.

2018

Marcos Túlio Raposo, Martha Cerqueira Reis, Ana Virgínia de Queiroz Caminha, Jörg Heukelbach, Lucy Anne Parker , Maria Pastor-Valero, Maria Ines Battistella Nemes. Grade 2 disabilities in leprosy patients from Brazil: Need for follow-up after completion of multidrug therapy. Abrir